Skip to content
Screener

Zoetis ZTS Total Restructuring charges and certain acquisition and divestiture-related costs

Total Restructuring charges and certain acquisition and divestiture-related costs at other companies

Pfizer logo
PfizerPFE
$457M+2,639%
Jabil logo
JabilJBL
$3M-66.7%
Novanta logo
NovantaNOVT
$12.5M-0.6%
Tenet Healthcare logo
Tenet HealthcareTHC
$31M+29.2%
Tenet Healthcare logo
Tenet HealthcareTHC
$31M+29.2%
Rambus logo
RambusRMBS
$0-100%

Other financials

Income statement

See full
Revenue$2.5B-0.2%
Gross profit$1.8B-0.8%
Net income$691.0M-4.8%
EPS (diluted)$1.65+1.2%

Balance sheet

See full
Cash & equivalents$1.5B-9.6%
Total debt$10.0B+47.1%
Total equity$3.1B-36.7%
Total assets$15.1B+4.1%

Cash flow

See full
Operating cash flow$655.0M+8.3%
CapEx$117.0M-19.9%
Free cash flow$538.0M+17.2%

Valuation

See full
Market cap$32.39B-50.1%
Enterprise value$40.91B-41.6%
P/E12.4×-12.7×
P/S3.4×-3.5×

Profitability

See full
Gross margin71.5%+0.2pp
Net margin27.5%-0.1pp
FCF margin24.3%+0.1pp

Returns & leverage

See full
Return on equity64.4%+12.3pp
Debt / equity3.2×+1.8×
Current ratio3.1×+1.3×

Where this comes from

Reported directly by Zoetis in its filing.

Tagged under the XBRL concept zts:RestructuringChargesAndAcquisitionAndDivestitureRelatedCosts.

The source filing: Zoetis’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 2:32 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001555280-26-000040
(MILLIONS OF DOLLARS)Three Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Restructuring charges and certain acquisition and divestiture-related costs:
Acquisition-related costs$2$1$4$1
Restructuring charges, net(a):
Employee termination costs, net745945
Asset impairment charges—22—22
Exit costs1212
Total Restructuring charges and certain acquisition and divestiture-related costs$77$30$99$30

Item 1. Financial Statements

FAQ

What is Zoetis's total restructuring charges and certain acquisition and divestiture-related costs?
Zoetis (ZTS) reported total restructuring charges and certain acquisition and divestiture-related costs of $77M in Q2 2026.
How has Zoetis's total restructuring charges and certain acquisition and divestiture-related costs changed year-over-year?
Zoetis's total restructuring charges and certain acquisition and divestiture-related costs increased by 156.7% year-over-year, from $30M to $77M.
What is the long-term trend for Zoetis's total restructuring charges and certain acquisition and divestiture-related costs?
Over 3 years (2022 to 2025), Zoetis's total restructuring charges and certain acquisition and divestiture-related costs has grown at a 66.7% compound annual growth rate (CAGR), from $11M to $51M.
What does total restructuring charges and certain acquisition and divestiture-related costs mean?
Total Restructuring charges and certain acquisition and divestiture-related costs as reported by ZOETIS INC..

Ask your AI about Zoetis's total restructuring charges and certain acquisition and divestiture-related costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude